Table 5.

Clinical characteristics of the study population for paired measures in plasma and genetic variants

	ICU Controls	Patients with Sepsis	Patients with ARDS
N	13	13	11
Sex, male/female	6/7	7/6	6/5
Race, AD/ED	7/6	7/6	6/5
Age	57 ± 19	63 ± 17	54 ± 18
APACHE II	18 ± 6.3	27 ± 5.8*	27 ± 7.6*
Mortality, %	0	23	45
TOC, day	3 (1–5)	5 (4–7)	4 (3–6)
Mechanic ventilation, %	38	54	100
Cancer, %	23	46	27
CLD, %	8	8	9
ESRF, %	23	23	36
COPD, %	15	23	9
Diabetes, %	62	31	18
CHF, %	38	23	9
AIDS, %	8	8	18
Site of infection
Lung, %	NA	54	55
Abdomen, %	NA	15	9
UTI, %	NA	8	9
Blood, %	NA	8	9
Other, %	NA	15	18

TOC, Time of collection; ESRF, end stage renal failure; CHF, congestive heart failure.

^*P < 0.05 for significant difference vs. ICU controls.